期刊文献+

复方甘草酸苷联合川芎嗪治疗酒精性肝病的疗效观察 被引量:4

Observation of curative effects of compound glycyrrhizin combined with ligustrazine on patients with alcoholic liver disease
原文传递
导出
摘要 目的:观察复方甘草酸苷联合川芎嗪治疗酒精性肝病的疗效。方法:将160例酒精性肝病患者随机分为对照组、复方甘草酸苷组、川芎嗪组及联合治疗组,治疗4周后观察肝功能、肝纤维化指标、转化生长因子β1(TGFβ1)、白细胞介素-6(IL-6)、瘦素(Leptin)及肿瘤坏死因子-α(TNF-α)。结果:各组治疗后肝功能较治疗前均显著好转,肝纤维化指标、TGFβ1、IL-6、Leptin及TNF-α较治疗前均显著下降(P<0.05),对照组、复方甘草酸苷组及川芎嗪组之间治疗后肝功能、肝纤维化指标、TGFβ1、IL-6、Leptin及TNF-α无显著性差异(P>0.05),联合治疗组治疗后肝功能较对照组、复方甘草酸苷组及川芎嗪组显著改善(P<0.05),肝纤维化指标、TGFβ1、IL-6、Leptin及TNF-α较对照组、复方甘草酸苷组及川芎嗪组显著下降(P<0.05)。结论:复方甘草酸苷联合川芎嗪治疗酒精性肝病有效。 Objective:To observe the curative effects of compound glycyrrhizin combined with ligustrazine on patients with alcoholic liver disease. Mcthods:160 cases of alcoholic liver disease were randomly divided into four groups:control group, compound glycyrrhizin group,ligustrazine group and combined treatment group. The parameters of hepatic function and fibrosis were observed four weeks after treatment. Results:The parameters of hepatic function were improved after treatment and fibrosis,TGFβ1, IL-6,Leptin, TNF-α after treatment in four groups were lower than those before treatment (P 〈 0.05). The parameters of hepatic function,fibrosis, TGFβ1 ,IL-6,Leptin and TNF-α after treatment among control group,compound glycyrrhizin group and ligustrazine group had no significance (P 〉 0.05). Compared with control group, compound glycyrrhizin group and ligustrazine group,the parameters of hepatic function, fibrosis, TGFβ1, IL-6, Leptin,TNF-α of combined treatment group after treatment were obviously improved (P 〈 0.05). Conclusion: Compound glycyrrhizin combined with ligustrazine are effective for the treatment of alcoholic liver disease.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2009年第11期1607-1610,共4页 Journal of Nanjing Medical University(Natural Sciences)
关键词 复方甘草酸苷 川芎嗪 酒精性肝病 疗效 compound glycyrrhizin ligustrazine alcoholic liver disease curative effect
  • 相关文献

参考文献10

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..酒精性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):164-166. 被引量:270
  • 2Savas MC, Koruk M, Pirim I, et al. Serum ubiquitin levels in patients with nonalcoholic steatohepatitis [J]. Hepatogastroenterology, 2003,50(51 ) : 738-741.
  • 3王欣,张明威,孙淑艳.酒精性肝病患者血清NO、TNF-α和IL-6的检测及意义[J].临床肝胆病杂志,2000,16(3):163-164. 被引量:6
  • 4赵彩彦,姜玲玲,李建梅,梁保丽,李丽.酒精性肝病患者血清瘦素水平的变化与临床意义[J].中国实用内科杂志,2004,24(9):545-546. 被引量:4
  • 5Lieber CS. New concepts of the pathogenesis of alcoholic liver disease lead to novel treatments [J ]. Curr Gastroenterol Rep, 2004,6( 1 ) : 60-65.
  • 6Tilg H,Diehl AM. Cytokines in alcoholic and nonalcoholic steato hepatitis [J]. N Engl J Med, 2000,343420) : 1467-1476.
  • 7Shen J, Sakaida I, Uchida K, et al. Leptin enhances TNF- alpha production via p38 and JNK MAPK in LPS-stimulated Kupffer cells[J]. Life Sci,2005,77(13) : 1502-1515.
  • 8Finck BN,Johnson RW. Tumor necrosis factor induces leptin production through tile p55 TNF receptor [J]. Am J Physiol Regul Integr Comp Physiol, 2000,278(2) : 537-543.
  • 9国家食品药品监督管理局药品审评中心 四川美康医药软件公司.药物临床信息参考[M].成都:四川科学技术出版社,2004..
  • 10王红 陈在忠 等.川芎嗪对大鼠肝纤维化脂质过氧化的影响[J].中华肝脏病杂志,2000,8:98-98.

二级参考文献26

  • 1胡国平,刘凯,赵连三.多烯磷脂酰胆碱(易善复)治疗酒精性肝病和脂肪肝的系统评价[J].肝脏,2005,10(1):5-7. 被引量:108
  • 2张丕利,梁扩寰,尹朝礼,唐望先,王天才,田德安,杜荔菁.肝硬化患者血中一氧化氮水平及其产生机制研究[J].中华内科杂志,1997,36(1):25-27. 被引量:37
  • 3王泰龄 赵静波 见:江正辉 王泰龄主编.酒精性肝病的病理变化[A].见:江正辉,王泰龄主编.酒精性肝病[C].北京:中国医药科技出版社,2001.25~47.
  • 4Ikejima K,Honda H,Hirose M,et al.As a profibrogenic factor in the liver.Gastroenterology,2000,118(6):A1014
  • 5Caro JF,Sinha MK,Kolaczynski JW,et al.Leptin:the tale of an obesity gene.Diabetes,1996,45(7):1455-1462
  • 6Kimura K,Tsuda K,Baba A,et al.Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin.Biochem Biophys Res Commun,2000,273(3):745-749
  • 7Potter JJ,Womack L,Mezey E,et al.Transdifferentiation rat hepatic stellate cells results in leptin expression.Biochem Biophys Res Commun,1998,244(1):178-182
  • 8任红 张定风 贾小平.病毒性肝炎肿瘤坏死因子和白细胞介素6的研究[J].中华医学杂志,1989,5(3):264-264.
  • 9Lok AS,McMahon B J; Practice Guidelines Committee,American Association for the Study of Liver Diseases (AASLD).Chronic hepatitis B:update of recommendations.Hepatology,2004,39:857-861.
  • 10Sanyal AJ.American Gastroenterological Association technical review on nonalcoholic fatty liver disease.Gastroenterology,2002,123:1705-1725.

共引文献375

同被引文献76

引证文献4

二级引证文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部